Viewing Study NCT03257033


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2026-02-27 @ 10:02 AM
Study NCT ID: NCT03257033
Status: RECRUITING
Last Update Posted: 2025-11-14
First Post: 2017-08-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
Sponsor: RenovoRx
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module